Key Record Dates
ClinicalTrials.gov Identifier: | NCT05432388 |
---|---|
Brief Title: | Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts |
First Submitted : | May 31, 2022 |
First Submitted that Met QC Criteria : | June 20, 2022 |
First Posted : | June 27, 2022 |
Last Update Submitted that Met QC Criteria : | January 21, 2024 |
Last Update Posted : | January 23, 2024 |